Take Home Message
The risk of sepsis after retrograde intrarenal surgery (RIRS) is low, at around 5%. Urosepsis is the most serious and possibly life-threatening complication of RIRS. Risk factors for sepsis after RIRS may be related to patients or surgery.
Keywords: Sepsis, Intrarenal ureteroscopy, Retrograde intrarenal surgery, Ureteroscopies, Risk factor, Infection
Abstract
Context
Nowadays, urolithiasis has become a highly prevalent disease. Recent studies indicate that retrograde intrarenal surgery (RIRS) is becoming more popular among surgical treatments due to the preference of patients and providers. This minimally invasive procedure results in high stone-free rates and relatively low morbidity; however, complications resulting from infection can still occur, including acute urinary tract infection, systemic inflammatory response syndrome, and sepsis.
Objective
To identify the independent risk factors for sepsis following RIRS, as well as general risk factors that may contribute to this life-threatening complication in the pre- and intraoperative periods.
Evidence acquisition
A literature review was conducted in April 2020 using the Medline, Scopus, and Cochrane databases. We searched the references of included papers.
Evidence synthesis
We screened 2306 manuscripts and selected 13 for inclusion. The sepsis rate ranged from 0.5% to 11.1%, and the septic shock rate ranged from 0.3% to 4.6%. All selected studies mentioned risks for sepsis and/or infective complications (including sepsis), but only four of them addressed independent risks for urosepsis. These independent risk factors were stone size, high irrigation pressure, prolonged stent dwelling time (>30 d), sepsis as an indication for stent insertion, female gender, positive intraoperative bladder urine culture, longer surgical time, and diabetes mellitus.
Conclusions
RIRS is associated with a low sepsis rate, according to the latest evidence. However, given that this is a serious life-threatening complication, knowing its potential risk factors is extremely important.
Patient summary
In this report, we looked at the outcome of sepsis after planned retrograde intrarenal surgery for stone disease in patients with and without comorbidities. This information may be useful for colleagues in their daily practice.
1. Introduction
Today, urolithiasis has become a major healthcare issue due to its increasing incidence of around 10% worldwide [1]. Its prevalence varies from 7–13% in the USA to 5–9% in Europe and 1–5% in Asia [2]. As a result of this increasing trend, it is extremely important to treat nephrolithiasis efficiently and safely.
Three commonest procedures deployed for managing upper tract stones are shockwave lithotripsy, retrograde intrarenal surgery (RIRS), and percutaneous nephrolithotomy [3], with recent studies indicating that RIRS is selectively preferred owing to patient and provider preference [4], [5]. This minimally invasive procedure results in high stone-free rates and relatively low morbidity; however, complications resulting from infection can still occur. The overall complication rate after RIRS is 9–25% [6] and mostly Clavien grade I or II [7]. Nonetheless, major infectious complications can develop, those of foremost importance being acute urinary tract infection (UTI), systemic inflammatory response syndrome (SIRS), and sepsis [8]. Sepsis has classically been defined as an infection with at least two of the four SIRS criteria: temperature >38°C or <36°C, heart rate >90/min, respiratory rate >20/min or PaCO2 <32 mmHg, and white blood cell count >12 000/mm3 or <4000/mm3 or >10% immature band [9]. However, the validity of SIRS as a descriptor of sepsis pathobiology has been questioned [10]. Recently, the sepsis definition was updated by the “Third International Consensus Definitions for Sepsis and Septic Shock” (Sepsis 3), and it is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection [10].
Sepsis caused by infection of the urogenital tract, also known as urosepsis, is the most serious complication of RIRS [11], [12]. It is therefore important to identify, before the surgery, the specific risk factors for postoperative sepsis. Prior systematic reviews, meta-analyses, and retrospective studies have identified risk factors for infective complications (ICs) following RIRS, but not specifically for sepsis [13], [14], [15], [16]. The aim of this systematic review is to identify the independent risk factors (IRFs) for sepsis following RIRS, as well as general risk factors that may contribute to this life-threatening complication in the pre- and intraoperative periods.
2. Evidence acquisition
2.1. Literature search and inclusion criteria
A literature review was conducted in April 2020 using the Medline, Scopus, and Cochrane databases, without time limits or language restriction. Separate searches were done with the following search terms: “sepsis,” “intrarenal,” “ureteroscopy,” “ureteroscopies,” “URS,” “risk factor,” and “infection.” This literature review followed the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) statement (Fig. 1) [17]. Owing to the heterogeneity of study outcomes and the lack of standardized quality appraisal, a narrative synthesis of data was performed.
Fig. 1.
Flowchart of the literature review.
2.2. Data abstraction
Studies that described potential risk factors related to sepsis or infectious complications (including sepsis) in patients who underwent RIRS were included. We excluded summaries (reviews) or reports that did not include sepsis among the ICs following RIRS as well as studies that did not mention the risk factors associated with septic complications after RIRS. For discussion purposes, prior systematic reviews or meta-analyses were included.
3. Evidence synthesis
Abstracts from 2306 reports (Fig. 1) were reviewed by two researchers (A.S. and S.D.) independently. Following the removal of duplicates, 2010 studies were enrolled for abstract screening.
3.1. Results
A total of 13 studies were included in this review after abstract screening and full-text review [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30]. The mean procedure time ranged from 25 to ≥210 min among the selected studies. The sepsis rate ranged from 0.5% to 11.1%, and the septic shock rate ranged from 0.3% to 4.6%. All selected studies mentioned risks for sepsis and/or ICs (including sepsis), but only four of them addressed independent risks for urosepsis. These IRFs were stone size, high irrigation pressure, prolonged stent dwelling time (>30 d), sepsis as an indication for stent insertion, female gender, positive intraoperative bladder urine culture, longer surgical time, and diabetes mellitus (DM). Results are summarized in Table 1.
Table 1.
Study, sepsis rate, and identified risk factors for urosepsis among included studies
Study | N | Male:female ratio | Mean age (yr) | Irrigation during URS | Mean operative time (min) | Type of infection (%) | Identified risk factors for urosepsis |
---|---|---|---|---|---|---|---|
Sugihara et al. (2013) [18], RC | 12 372 | 7918:4454 | ≤59–≥80 | NA | ≤59–≥210 | Sepsisa Septic shocka |
Longer surgical time Lower hospital volume |
Hu et al., 2016 [19], RCC | 332 | 185:147 | 43 | Gravity at 80, 120, and 160 mmHg | NA | Sepsis: 25 (7.5) Severe sepsis: 24 (7.2) Septic shock: 10 (3) |
Stone sizeb High irrigation pressureb |
Blackmur et al. (2016) [23], PC | 462 | NA | [55] | NA | NA | Sepsis: 34 (7.4) | Preop. urine culture (+) |
Nevo et al. (2017) [24], PC | 1256 | 870:386 | [57] | Pressurized irrigation: 40 mmHgc 90 mmHgd |
[51] | Sepsis: 36 (2.8) | Prolonged stent dwelling time (>30 d)b Sepsis as an indication for stent insertionb Female genderb |
Bloom et al. (2017) [25], RC | 345 | 173:172 | 50 | NA | 84 | Sepsis: 15 (4.3) | UTI treatment within the last month Prior endoscopic procedures Multiple comorbidities Longer surgical time |
Xu et al. (2018) [26], RC | 305 | 144:161 | 51 | Gravity at 60, 80, and 100 mmHg | 25 | Sepsis: 31 (10.2) Septic shock: 14 (4.6) |
High irrigation pressureb Longer surgical timeb DMb |
Ogreden et al. (2018) [27], RC | 72 | 56:16 | 44 | NA | NA | Fever: 38 (52.8) UTI: 27 (37.5) Sepsis: 8 (11.1) |
Stent insertion following URS (ureteral stones) in patients with PFS |
Ozgor et al. (2019) [28], PC | 494 | 273:221 | 35 | Gravity (<74 mmHg) | 65 | Fevera Sepsisa Septic shocka |
Longer surgical time (>60 min) Renal abnormality Age (≤40 yr) |
Bai et al. (2019) [29], RC | 1421 | 880:541 | 59 | Manual irrigation pump | [62] | Sepsis: 12 (0.8) | Preop. MDR urine culture (+) Longer surgical time |
Díaz Pérez et al. (2019) [30], RC | 246 | 155:91 | 52 | Manual irrigation pump | 68 | Sepsis: 18 (7.3) | Female gender Preop. urine culture (+) History of urosepsis Prior antibiotic therapy Preop. stent insertion Residual lithiasis after URS |
Wood et al. (2019) [20], PC | 281 | 193:88 | 60 | NA | NA | Sepsis: 16 (5.7) | Intraop. bladder urine culture (+)b Female gender Steroid use Preop. urine culture (+) Stent-end culture (+) Kidney urine culture (+) |
Zisman et al. (2020) [21], RC | 287 | 211: 76 | 51 | NA | NA | Fever: 13 (4.5) Sepsis: 9 (3.1) |
Preop. urine culture (+) Stone location (upper and distal ureteral stone) Conventional APT (oral ciprofloxacin) |
Peng et al. (2020) [22], RC | 1493 | 913:580 | 49 | Syringe manual irrigation | 30 | Fever: 75 (4.9) Sepsis: 8 (0.5) Septic shock: 4 (0.3) |
Female gender Preop. urine culture (+) Infection stone Postop. neutrophil ratio >75% |
APT = antibiotic prophylactic treatment; DM = diabetes mellitus; Intraop. = intraoperative; MDR = multidrug resistance; N = sample size; NA = not available; PC = prospective cohort; PFS = perirenal fat stranding; Postop. = postoperative; Preop. = preoperative; RC = retrospective cohort; RCC = retrospective case-control; URS = ureteroscopy; UTI = urinary tract infection.
Values in [ ] indicate medians.
% Not specified.
Independent risk factors of urosepsis.
Semirigid ureteroscopy.
Flexible ureteroscopy.
3.1.1. Patient-related risk factors
3.1.1.1. Stone characteristics
In a study of 332 patients with ureteral stones between 9.2 and 10.3 mm, the stone size was found to be an IRF for sepsis following RIRS [19]. The bigger the stone, the higher the risk of sepsis. The authors did not find stone site (proximal, mid, or distal ureter) or stone side to be a risk factor for urosepsis. Zisman et al. [21] carried out a study that included 287 patients, of whom 3.1% developed sepsis in the postoperative period. Based on their findings, stone location was also found to be a risk factor for post-RIRS sepsis. Patients undergoing RIRS for kidney stones had higher sepsis rates than patients with distal or proximal ureteral stones. This difference was seen only in those patients treated with conventional antibiotic prophylactic treatment (APT; ciprofloxacin 500 mg p.o. b.i.d.); however, when two drugs were used (one dose of gentamycin 240 mg intravenously [i.v.] and ampicillin 1 g i.v. t.i.d.), this difference disappeared. In another study [22] conducted in 1493, among patients who underwent RIRS, a total of 73 suffered postoperative fever (POV; 4.9%), eight developed sepsis (0.5%), and four developed septic shock (0.3%). The authors found that patients with infection stones (ie, struvite, carbonate apatite, and ammonium urate) were more likely to suffer postoperative ICs and concluded that infection stones were an IRF of post-RIRS fever.
3.1.1.2. Gender, age, and comorbidities
In three studies [20], [22], [30], female gender was found to be a risk factor for sepsis, but only one study [24] concluded that female gender was an IRF for sepsis after RIRS.
Another study found that younger patients had more ICs (34.8 vs 44.7 yr old, p < 0.001), suggesting that patients under the age of 40 yr are more likely to suffer from this event [28]. The authors also concluded that the presence of renal abnormalities was significantly more common in patients with infectious complications (12.3% vs 35.5%, p < 0.001).
Furthermore, among patient comorbidities, we found that DM was considered an IRF for sepsis [26].
3.1.1.3. Sepsis and antibiotic therapy prior to RIRS
Díaz Pérez et al. [30] performed RIRS on 246 patients; 18 of these patients (7.3%) developed urosepsis. They found that patients who experienced the clinical onset of lithiasis in the form of urinary sepsis were more likely to develop sepsis after RIRS. Additionally, they also mentioned that other risk factors for sepsis were a history of antibiotic therapy and double J dwelling during the nephritic colic. Moreover, Nevo et al. [24] also found that patients who undergo ureteroscopy after ureteric stent insertion have a higher risk of postoperative sepsis. They concluded that prolonged stent dwelling time (>30 d) and sepsis as indications for stent insertion were IRFs for sepsis.
Another study [25], which included 345 elective RIRS patients, had a sepsis rate of 4.3%. According to the authors, patients with prior endoscopic procedures and especially those recently treated for a urinary infection should be monitored carefully after RIRS for signs of sepsis.
3.1.1.4. Urine culture
The presence of a positive preoperative urine culture was associated with postoperative sepsis [20], [23], [29], [30] and infectious complications in general [21], [22]. Blackmur et al. [23] emphasized on the midstream sample of urine, which they found to be significantly associated with postoperative urosepsis in not prestented patients. Bai et al. [29] concluded that positive preoperative multidrug resistance (MDR) urine culture was significantly associated with urosepsis after RIRS. One of the largest cohort studies that examined five different urinary tract cultures and the relationship between these cultures and sepsis after RIRS found that the positive intraoperative bladder and kidney urine cultures as well as the stent-end culture were highly related to sepsis [20]. Moreover, a positive intraoperative bladder urine culture was an IRF for postoperative sepsis.
3.1.2. Surgery-related risk factors
3.1.2.1. Antibiotic prophylaxis
One study focused only on the APT for RIRS. In their study, the authors compared the conventional APT, ciprofloxacin 500 mg p.o. b.i.d, with a new double-drug APT, gentamycin 240 mg i.v., and ampicillin 1g i.v. t.i.d. [21]. Based on the analysis of 287 patients, the sepsis incidence was 3.1%, and it was higher in patients who used the conventional APT (7.5% vs 0.5%).
3.1.2.2. Surgical time
Sugihara et al. [18] showed a positive linear relationship between operative duration and severe adverse events (AEs), including sepsis. Similar results were reported in other studies, where longer operative time was also a risk factor for developing sepsis after RIRS [25], [26], [28], [29]. Moreover, Xu et al. [26] found that operation time was an IRF for post-RIRS sepsis.
3.1.2.3. Irrigation pressure
High irrigation pressure was found to be an IRF for urosepsis in two different studies.
The first study, by Hu et al. [19], used irrigation pressure of 80, 120, and 160 mmHg, and the second study, by Xu et al. [26], used irrigation pressure of 60, 80, an 100 mmHg. Both studies concluded that sepsis rates after RIRS increased proportionately with higher irrigation pressure.
3.1.2.4. Stenting
Ogreden et al. [27] evaluated the impact of stenting after RIRS in patients with ureteral stones and perirenal fat stranding, and concluded that double J stent insertion following RIRS increased the risk of postoperative infections in these patients.
3.1.2.5. Lower hospital volume
Sugihara et al. [18] hypothesized that hospital volume was inversely associated with the occurrence of severe AEs in RIRS, as well as extracorporeal shockwave lithotripsy and percutaneous nephrolithotomy. Compared with low-volume hospitals (≤15 RIRS procedures per year), medium-volume ones (16–38 RIRS procedures per year) reported a 20% reduction in severe AEs, including sepsis. Additionally, high-volume hospitals (≥39 RIRS procedures per year) achieved an additional 20% reduction in severe AEs.
3.2. Discussion
Nowadays, RIRS is generally considered an outpatient procedure due to its safety [31]. However, even if rare, bleeding and infectious complications may occur [32]. Among infectious complications, POF is most common [33], and unplanned hospitalization is primarily caused by POF or SIRS [34]. POF/SIRS must be recognized and managed as soon as possible to avoid progression to sepsis, which has a mortality rate of 28.3–41.1% [12].
Study definitions of sepsis were heterogeneous. Most of the studies included in this review [20], [21], [23], [24], [27], [28], [29], [30] used the initial definition of sepsis that claimed that sepsis resulted from a host’s SIRS to infection [9]. Two studies [19], [26] used the most recent definition from Sepsis 3 [10], whereas only one study [22] based their sepsis diagnosis on two or more criteria of the quick sepsis-related organ failure assessment: systolic blood pressure <100 mmHg, highest respiratory rate >22 bpm, and lowest Glasgow coma score <15. Based on a recent systematic review and meta-analysis of urosepsis following RIRS, rates of postoperative sepsis ranged from 0.2% to 17.8% [35], which is in line with the sepsis rate we obtained in our study, which ranged from 0.5% to 11.1%. In spite of its low rate, urosepsis carries risks of extended hospitalization, unplanned intensive care admission, and death [36]. Identifying early predictors of sepsis after RIRS is imperative in determining patients' risk stratification as well as the intraoperative management.
Across the published literature regarding factors associated with post-RIRS sepsis, there is a lack of consensus. The previous studies either reported general risk factors for IC [14], [15] or included studies where sepsis was mentioned as a potential complication, without specifying the potential risk factors related to sepsis [13], [32], [37]. In our study, we found that female gender, DM, stone size, sepsis as an indication for stent insertion, prolonged stent dwelling time (>30 d) before RIRS, high irrigation pressure, longer surgical time, and positive intraoperative bladder urine culture were IRFs for sepsis after RIRS.
It has previously been published that women experience higher sepsis rate after ureteroscopy than men [7], [15], [37]. The shorter urethral length of women could explain this, as it increases the possibility of colonization by perineal and rectal bacteria [15], [38]. Martov et al. [39] confirmed that female gender was a specific risk factor for infectious complications after RIRS. In contrast, other reports state that female gender is irrelevant in the occurrence of SIRS or sepsis [11], [40]. In our study, female gender was constantly found as a risk factor for sepsis [19], [21], [23], [29]. Moreover, patients with comorbidities were more likely to develop fever or UTI following RIRS [39]. In terms of comorbidities related to urosepsis, the results were not consistent. While some authors showed that comorbidities such as ischemic heart disease, chronic kidney disease (CKD), immunodeficiency, and chronic indwelling urinary catheter were not associated with a higher urosepsis risk [23], [30], others found that steroid use and CKD were significant risk factors for urosepsis [20]. However, among comorbidities, DM has been highlighted as a potentially significant risk factor for postoperative infections [23], [41] and also as an IRF for urosepsis after RIRS [42]. This result was consistent with our study, which showed that DM was also an IRF for urosepsis [26]. Concerning anomalous kidneys, there was only one study that included patients with kidney malformations (ie, horseshoe kidney) [28]. The authors found that anomalous kidney was a predictive factor of infectious complications following RIRS. Recently, a high-volume international multicenter study, including 19 high-volume centers, concluded that RIRS in patients with anomalous kidneys is safe and effective with a high single-stage stone-free rate and low complication rate [43].
Another risk factor was the stone size. The size of the stone was cited as an IRF for sepsis following RIRS; the bigger the stone, the greater the risk for urosepsis [19]. Additionally, longer operative time was also associated with a higher sepsis risk. This is supported by different authors [24], [44] who also found that longer operative time was related to severe AEs after RIRS, such as sepsis. Ozgor et al. [28] determined that surgeries lasting over 1 h doubled the risk of developing infectious complications. Xu et al. [26] found operative time to be an IRF for sepsis; hence, it is extremely important to control this factor. Furthermore, a long RIRS duration may also cause persistently high intrarenal pressure. High irrigation pressure can lead to pyelorenal backflow, which occurs when contents of the renal pelvis and calyceal system permeate beyond their normal limits, to the peripelvic sinus tissue (pyelosinous backflow), renal vein (pyelovenous backflow), collecting ducts and tubules (pyelotubular backflow), or renal interstitium (pyelointerstitial backflow) [45]. This condition occurs at pressure as low as 13.6–27.2 cmH2O, and at 40.8–68 cmH2O it becomes evident [45], [46]. All this may also increase the risk of infection after surgery [47] due to the entrance of pathogens and endotoxins into the blood stream [47], [48]. Xu et al. [26] found that patients who underwent RIRS with high irrigation pressure had a significantly higher risk of postoperative urosepsis, and classified this item as an IRF for sepsis following RIRS. Hence, in clinical practice, RIRS should be performed under low irrigation pressure (below 40 cmH2O or 30 mmHg). It has been proposed that small-sized ureteral access sheaths (UASs) can provide low intrarenal pressure with good irrigation inflow and outflow when using a small-sized flexible ureteroscope [49]. Nonetheless, UASs were not used in either of the two studies [19], [26] that focused on irrigation pressure and urosepsis. One study only mentioned that UASs did not reduce the risk of urosepsis after RIRS [23].
Multiple studies have found pyuria or positive preoperative urine cultures to be associated with ICs after RIRS [34]. Kazan et al. [50] performed a study about the role of preoperative urinalysis in predicting postoperative infection after RIRS in patients with and without a history of UTI, and the results showed that postoperative infection developed more frequently in patients who have had a history of UTI. Moreover, positive preoperative MDR urine culture has highly been associated with urosepsis after RIRS, despite appropriate preoperative antibiotic therapy [29]. This is of particular importance because the prevalence of MDR pathogens in patients with UTI is gradually increasing worldwide, perhaps due to the inappropriate antibiotic use and unnecessary anti-infective treatments [51]. The presence of positive preoperative urine cultures is associated with intraoperative stent colonization, but not with intraoperative urine colonization [20]. This brings us to another important urine culture highly associated with infectious complications, the intraoperative bladder urine culture. This urine culture was found to be an IRF for sepsis after RIRS. A nonsterile bladder urine culture was the strongest predictor of postoperative urosepsis, as it was 11 times more likely to cause the disease than a sterile culture [20].
There is still some debate, however, as to whether previous sepsis and emergency drainage pose a risk for developing sepsis after RIRS. Nevo et al. [24] found that sepsis as an indication for stent insertion and prolonged stent dwelling time before RIRS were IRFs for urosepsis. Stent dwelling time of >30 d was associated with a five-fold higher risk of urosepsis compared with dwelling time of ≤30 d. Similar results were found by Moses et al. [31], who demonstrated that indwelling ureteric stents before the procedure or longer operating time was associated with a higher rate of infection-related hospital readmissions. According to a recent prospective study, elective RIRS achieved excellent outcomes in patients who previously presented with obstructing calculi and sepsis needing emergency decompression [52]. This latest study included only patients who underwent prior sepsis; meanwhile, the previous ones [24], [31] included patients who underwent elective RIRS in general. It would be important to determine the safety of stent dwell time in this high-risk group [52]. On the contrary, it has also been proposed that patients with positive preoperative midstream sample of urine and no stent in situ are more likely to be obstructed and have stagnant urine, which could become infected and lead to urosepsis. It may therefore be suggested that the drainage provided by the stent outweighs the risk of foreign body and biofilm formation in these cases.
In addition, only one study included in this review evaluated a potential postoperative event that could be related to sepsis, the presence of residual fragments. According to this report [30], the presence of residual fragments on image examination (c-ray, ultrasound, or noncontrast uroscanner) in the 3 mo after surgery was significantly associated with the development of urinary sepsis after RIRS. Further studies need to be conducted to confirm this statement.
3.3. Limitations
The study is not without limitations. First, most of the studies included in this analysis were retrospective, except for two. Second, it was not possible to evaluate whether a publication bias was present. Third, indications for preoperative stent placement and average dwell time were rarely reported, limiting our ability to analyze these data in a more thorough manner. Finally, important information such as the use of UASs, laser settings, and surgeon experience is missing in most publications.
4. Conclusions
RIRS is associated with a low sepsis rate, according to the latest evidence. However, given that this is a serious life-threatening complication, knowing its potential risk factors is extremely important. Female gender, DM, stone size, sepsis as an indication for stent insertion, prolonged stent dwelling time (>30 d) before RIRS, high irrigation pressure, longer surgical time, and positive intraoperative bladder urine culture were IRFs for sepsis after RIRS. This information may be useful for colleagues in their daily practice.
Author contributions: Mariela Corrales had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Study concept and design: Corrales, Traxer.
Acquisition of data: Sierra, Doizi.
Analysis and interpretation of data: Corrales, Doizi, Sierra.
Drafting of the manuscript: Corrales, Traxer.
Critical revision of the manuscript for important intellectual content: Traxer, Doizi.
Statistical analysis: None.
Obtaining funding: None.
Administrative, technical, or material support: Doizi.
Supervision: Traxer.
Other: None.
Financial disclosures: Mariela Corrales certifies that all conflicts of interest, including specific financial interests and relationships and affiliations relevant to the subject matter or materials discussed in the manuscript (eg, employment/affiliation, grants or funding, consultancies, honoraria, stock ownership or options, expert testimony, royalties, or patents filed, received, or pending), are the following: None.
Funding/Support and role of the sponsor: None.
Associate Editor: Silvia Proietti
References
- 1.Rukin N.J., Siddiqui Z.A., Chedgy E.C.P., Somani B.K. Trends in upper tract stone disease in England: evidence from the Hospital Episodes Statistics database. Urol Int. 2017;98:391–396. doi: 10.1159/000449510. [DOI] [PubMed] [Google Scholar]
- 2.Sorokin I., Mamoulakis C., Miyazawa K., Rodgers A., Talati J., Lotan Y. Epidemiology of stone disease across the world. World J Urol. 2017;35:1301–1320. doi: 10.1007/s00345-017-2008-6. [DOI] [PubMed] [Google Scholar]
- 3.Türk C, Neisius A, Petrik A, et al. EAU guidelines on urolithiasis. 2020.
- 4.Raheem O.A., Khandwala Y.S., Sur R.L., Ghani K.R., Denstedt J.D. Burden of urolithiasis: trends in prevalence, treatments, and costs. Eur Urol Focus. 2017;3:18–26. doi: 10.1016/j.euf.2017.04.001. [DOI] [PubMed] [Google Scholar]
- 5.Pietropaolo A., Proietti S., Geraghty R., et al. Trends of “urolithiasis: interventions, simulation, and laser technology” over the last 16 years (2000–2015) as published in the literature (PubMed): a systematic review from European Section of Uro-technology (ESUT) World J Urol. 2017;35:1651–1658. doi: 10.1007/s00345-017-2055-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Türk C., Petřík A., Sarica K., et al. EAU guidelines on interventional treatment for urolithiasis. Eur Urol. 2016;69:475–482. doi: 10.1016/j.eururo.2015.07.041. [DOI] [PubMed] [Google Scholar]
- 7.Baboudjian M., Gondran-Tellier B., Abdallah R., et al. Predictive risk factors of urinary tract infection following flexible ureteroscopy despite preoperative precautions to avoid infectious complications. World J Urol. 2020;38:1253–1259. doi: 10.1007/s00345-019-02891-8. [DOI] [PubMed] [Google Scholar]
- 8.Pietropaolo A., Geraghty R.M., Veeratterapillay R., et al. A machine learning predictive model for post-ureteroscopy urosepsis needing intensive care unit admission: a case-control YAU endourology study from nine European centres. J Clin Med. 2021;10:3888. doi: 10.3390/jcm10173888. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Bone R.C., Balk R.A., Cerra F.B., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101:1644–1655. doi: 10.1378/chest.101.6.1644. [DOI] [PubMed] [Google Scholar]
- 10.Singer M., Deutschman C.S., Seymour C., et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) JAMA. 2016;315:801–810. doi: 10.1001/jama.2016.0287. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Ratajczak J.M., Hladun T., Krenz B., Bromber K., Salagierski M., Marczak M. Can we identify patients in danger of complications in retrograde intrarenal surgery?—A retrospective risk factors analysis. Int J Environ Res Public Health. 2022;19:1114. doi: 10.3390/ijerph19031114. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Wagenlehner F.M., Lichtenstern C., Rolfes C., et al. Diagnosis and management for urosepsis. Int J Urol. 2013;20:963–970. doi: 10.1111/iju.12200. [DOI] [PubMed] [Google Scholar]
- 13.Dybowski B., Bres-Niewada E., Rzeszutko M., et al. Risk factors for infectious complications after retrograde intrarenal surgery—a systematic review and narrative synthesis. Cent Eur J Urol. 2021;74:437–445. doi: 10.5173/ceju.2021.250. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Ma Y.C., Jian Z.Y., Yuan C., Li H., Wang K.J. Risk factors of infectious complications after ureteroscopy: a systematic review and meta-analysis based on adjusted effect estimate. Surg Infect (Larchmt) 2020;21:811–822. doi: 10.1089/sur.2020.013. [DOI] [PubMed] [Google Scholar]
- 15.Le S.J., Xu J.N., Ouyang J. Risk factors of infectious complications following ureteroscopy: a systematic review and meta-analysis. Urol Int. 2020;104:113–124. doi: 10.1159/000504326. [DOI] [PubMed] [Google Scholar]
- 16.Uchida Y., Takazawa R., Kitayama S., Tsujii T. Predictive risk factors for systemic inflammatory response syndrome following ureteroscopic laser lithotripsy. Urolithiasis. 2018;46:375–381. doi: 10.1007/s00240-017-1000-3. [DOI] [PubMed] [Google Scholar]
- 17.Moher D., Liberati A., Tetzlaff J., Altman D.G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8:336–341. doi: 10.1016/j.ijsu.2010.02.007. [DOI] [PubMed] [Google Scholar]
- 18.Sugihara T., Yasunaga H., Horiguchi H., et al. A nomogram predicting severe adverse events after ureteroscopic lithotripsy: 12 372 patients in a Japanese national series. BJU Int. 2013;111:459–466. doi: 10.1111/j.1464-410X.2012.11594.x. [DOI] [PubMed] [Google Scholar]
- 19.Hu W., Zhou P.H., Wang W., Zhang L., Zhang X.-B. Prognostic value of adrenomedullin and natriuretic peptides in uroseptic patients induced by ureteroscopy. Mediators Inflamm. 2016;2016:9743198. doi: 10.1155/2016/9743198. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Wood B., Habashy D., Mayne D.J., Dhar A., Purvis C., Skyring T. The utility of preoperative and intraoperative cultures for guiding urosepsis empirical treatment. J Clin Urol. 2019;13:132–139. [Google Scholar]
- 21.Zisman A., Badaan S., Kastin A., Kravtsov A., Amiel G.E., Mullerad M. Tailoring antibiotic prophylaxis for ureteroscopic procedures based on local resistance profiles may lead to reduced rates of infections and urosepsis. Urol Int. 2020;104:106–112. doi: 10.1159/000503905. [DOI] [PubMed] [Google Scholar]
- 22.Peng Y., Liu M., Ming S., Yu W., Li L., Lu C., et al. Safety of a novel thulium fiber laser for lithotripsy: an in vitro study on the thermal effect and its impact factor. J Endourol. 2020;34:88–92. doi: 10.1089/end.2019.0426. [DOI] [PubMed] [Google Scholar]
- 23.Blackmur J.P., Maitra N.U., Marri R.R., Housami F., Malki M., Mcilhenny C. Analysis of factors’ association with risk of postoperative urosepsis in patients undergoing ureteroscopy for treatment of stone disease. J Endourol. 2016;30:963–969. doi: 10.1089/end.2016.0300. [DOI] [PubMed] [Google Scholar]
- 24.Nevo A., Mano R., Baniel J., Lifshitz D.A. Ureteric stent dwelling time: a risk factor for post-ureteroscopy sepsis. BJU Int. 2017;120:117–122. doi: 10.1111/bju.13796. [DOI] [PubMed] [Google Scholar]
- 25.Bloom J., Fox C., Fullerton S., Matthews G., Phillips J. Sepsis after elective ureteroscopy. Can J Urol. 2017;24:9017–9023. [PubMed] [Google Scholar]
- 26.Xu Y., Min Z., Wan S.P., Nie H., Duan G. Complications of retrograde intrarenal surgery classified by the modified Clavien grading system. Urolithiasis. 2018;46:197–202. doi: 10.1007/s00240-017-0961-6. [DOI] [PubMed] [Google Scholar]
- 27.Ogreden E., Oǧuz U., Demirelli E., Benli E., Özen Ö. The impact of ureteral double-J stent insertion following ureterorenoscopy in patients with ureteral stones accompanied by perirenal fat stranding. Arch Ital Di Urol Androl. 2018;90:15–19. doi: 10.4081/aiua.2018.1.15. [DOI] [PubMed] [Google Scholar]
- 28.Ozgor F., Sahan M., Cubuk A., Ortac M., Ayranci A., Sarilar O. Factors affecting infectious complications following flexible ureterorenoscopy. Urolithiasis. 2019;47:481–486. doi: 10.1007/s00240-018-1098-y. [DOI] [PubMed] [Google Scholar]
- 29.Bai T., Yu X., Qin C., et al. Identification of factors associated with postoperative urosepsis after ureteroscopy with holmium:yttrium-aluminum-garnet laser lithotripsy. Urol Int. 2019;103:311–317. doi: 10.1159/000502159. [DOI] [PubMed] [Google Scholar]
- 30.Díaz Pérez D., Laso García I., Sánchez Guerrero C., et al. Urinary sepsis after endourological ureterorenoscopy for the treatment of lithiasis. Actas Urol Esp. 2019;43:293–299. doi: 10.1016/j.acuro.2019.02.001. [DOI] [PubMed] [Google Scholar]
- 31.Moses R.A., Ghali F.M., Pais V.M., Hyams E.S. Unplanned hospital return for infection following ureteroscopy—can we identify modifiable risk factors? J Urol. 2016;195:931–936. doi: 10.1016/j.juro.2015.09.074. [DOI] [PubMed] [Google Scholar]
- 32.Bapir R., Bhatti K.H., Eliwa A., et al. Infectious complications of endourological treatment of kidney stones: a meta-analysis of randomized clinical trials. Arch Ital Urol Androl. 2022;94:97–106. doi: 10.4081/aiua.2022.1.97. [DOI] [PubMed] [Google Scholar]
- 33.Mitsuzuka K., Nakano O., Takahashi N., Satoh M. Identification of factors associated with postoperative febrile urinary tract infection after ureteroscopy for urinary stones. Urolithiasis. 2016;44:257–262. doi: 10.1007/s00240-015-0816-y. [DOI] [PubMed] [Google Scholar]
- 34.Southern J.B., Higgins A.M., Young A.J., et al. Risk factors for postoperative fever and systemic inflammatory response syndrome after ureteroscopy for stone disease. J Endourol. 2019;33:516–522. doi: 10.1089/end.2018.0789. [DOI] [PubMed] [Google Scholar]
- 35.Bhojani N., Miller L.E., Bhattacharyya S., Cutone B., Chew B.H. Risk factors for urosepsis after ureteroscopy for stone disease: a systematic review with meta-analysis. J Endourol. 2021;35:991–1000. doi: 10.1089/end.2020.1133. [DOI] [PubMed] [Google Scholar]
- 36.Cindolo L., Castellan P., Scoffone C.M., et al. Mortality and flexible ureteroscopy: analysis of six cases. World J Urol. 2016;34:305–310. doi: 10.1007/s00345-015-1642-0. [DOI] [PubMed] [Google Scholar]
- 37.Chugh S., Pietropaolo A., Montanari E., Sarica K., Somani B.K. Predictors of urinary infections and urosepsis after ureteroscopy for stone disease: a systematic review from EAU Section of Urolithiasis (EULIS) Curr Urol Rep. 2020;21:16. doi: 10.1007/s11934-020-0969-2. [DOI] [PubMed] [Google Scholar]
- 38.Khusid J.A., Hordines J.C., Sadiq A.S., Atallah W.M., Gupta M. Prevention and management of infectious complications of retrograde intrarenal surgery. Front Surg. 2021;8:718583. doi: 10.3389/fsurg.2021.718583. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Martov A., Gravas S., Etemadian M., et al. Postoperative infection rates in patients with a negative baseline urine culture undergoing ureteroscopic stone removal: a matched case-control analysis on antibiotic prophylaxis from the CROES URS global study. J Endourol. 2015;29:171–180. doi: 10.1089/end.2014.0470. [DOI] [PubMed] [Google Scholar]
- 40.Sammon J.D., Ghani K.R., Karakiewicz P.I., et al. Temporal trends, practice patterns, and treatment outcomes for infected upper urinary tract stones in the United States. Eur Urol. 2013;64:85–92. doi: 10.1016/j.eururo.2012.09.035. [DOI] [PubMed] [Google Scholar]
- 41.Mariappan P., Tolley D.A. Endoscopic stone surgery: minimizing the risk of post-operative sepsis. Curr Opin Urol. 2005;15:101–105. doi: 10.1097/01.mou.0000160624.51484.60. [DOI] [PubMed] [Google Scholar]
- 42.Xu C.G., Guo Y.L. Diagnostic and prognostic values of BMPER in patients with urosepsis following ureteroscopic lithotripsy. Biomed Res Int. 2019;2019:8078139. doi: 10.1155/2019/8078139. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.García Rojo E., Teoh J.Y.C., Castellani D., et al. Real-world global outcomes of retrograde intrarenal surgery in anomalous kidneys: a high volume international multicenter study. Urology. 2022;159:41–47. doi: 10.1016/j.urology.2021.10.003. [DOI] [PubMed] [Google Scholar]
- 44.Fan S., Gong B., Hao Z., et al. Risk factors of infectious complications following flexible ureteroscope with a holmium laser: a retrospective study. Int J Clin Exp Med. 2015;8:11252. [PMC free article] [PubMed] [Google Scholar]
- 45.Tokas T., Herrmann T.R.W., Skolarikos A., Nagele U. Pressure matters: intrarenal pressures during normal and pathological conditions, and impact of increased values to renal physiology. World J Urol. 2019;37:125–131. doi: 10.1007/s00345-018-2378-4. [DOI] [PubMed] [Google Scholar]
- 46.Jung H.U., Frimodt-Møller P.C., Osther P.J., Mortensen J. Pharmacological effect on pyeloureteric dynamics with a clinical perspective: a review of the literature. Urol Res. 2006;34:341–350. doi: 10.1007/s00240-006-0069-x. [DOI] [PubMed] [Google Scholar]
- 47.Scotland K.B., Lange D. Prevention and management of urosepsis triggered by ureteroscopy. Res Rep Urol. 2018;10:43–49. doi: 10.2147/RRU.S128071. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Zhong W., Leto G., Wang L., Zeng G. Systemic inflammatory response syndrome after flexible ureteroscopic lithotripsy: a study of risk factors. J Endourol. 2015;29:25–28. doi: 10.1089/end.2014.0409. [DOI] [PubMed] [Google Scholar]
- 49.De Coninck V., Keller E.X., Rodríguez-Monsalve M., Audouin M., Doizi S., Traxer O. Systematic review of ureteral access sheaths: facts and myths. BJU Int. 2018;122:959–969. doi: 10.1111/bju.14389. [DOI] [PubMed] [Google Scholar]
- 50.Kazan O., Cakici M., Keser F., et al. The role of preoperative urinalysis in predicting postoperative infection after retrograde intrarenal surgery in patients with sterile urine culture. Turkish J Urol. 2022;48:136–141. doi: 10.5152/tud.2022.21331. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Zowawi H.M., Harris P.N.A., Roberts M.J., et al. The emerging threat of multidrug-resistant Gram-negative bacteria in urology. Nat Rev Urol. 2015;12:570–584. doi: 10.1038/nrurol.2015.199. [DOI] [PubMed] [Google Scholar]
- 52.Pietropaolo A., Hendry J., Kyriakides R., et al. Outcomes of elective ureteroscopy for ureteric stones in patients with prior urosepsis and emergency drainage: prospective study over 5 yr from a tertiary endourology centre. Eur Urol Focus. 2020;6:151–156. doi: 10.1016/j.euf.2018.09.001. [DOI] [PubMed] [Google Scholar]